Pretzel Therapeutics
PrivateLast Round
VC Round
Jul 11, 2025
Total Funding Raised
$72.5M
Company Overview
Pretzel Therapeutics is a biotechnology company developing first-in-class therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pretzel Therapeutics Comparables
Compare Pretzel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morningside | 85% | |
| Vincerx Pharma | 78% | |
| Pharming Group N.V. | 78% |
Pretzel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 11, 2025 | ||||
| Series A | Sep 12, 2022 |
Pretzel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Series A |
| GV | Series A |
| ARCH Venture Partners | Series A |
| United Mitochondrial Disease Foundation | VC Round |
| HealthCap | Series A |
| Eir Ventures | Series A |
| Invus Opportunities | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
PX578 data presented at the 2026 MDA Clinical & Scientific Conference.
- Mar 11, 2026
Presented data at the 2026 MDA Clinical & Scientific Conference.
Pretzel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pretzel Therapeutics's valuation, stock price, and market status.
Is Pretzel a public or private company?
Pretzel is a private company.
What is the current stock price of Pretzel?
Pretzel is a private company with no public stock price. No recent secondary market data is available.
How much is Pretzel worth (valuation)?
Valuation information for Pretzel is not publicly available.
Can I buy Pretzel stock?
Pretzel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pretzel's last funding round?
Pretzel's most recent funding round was VC Round on July 14, 2025.
Who are the main investors in Pretzel?
Key investors in Pretzel include United Mitochondrial Disease Foundation, ARCH Venture Partners, Mubadala Capital.
Will Pretzel IPO soon?
No public IPO plans have been announced for Pretzel.
How can I track Pretzel secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pretzel's secondary market activity and sign up for updates.